116 related articles for article (PubMed ID: 29293034)
61. Evaluation of tumor-prostheses over time: Complications, functional outcome, and comparative statistical analysis after resection and reconstruction in orthopedic oncologic conditions in the lower extremities.
Holm CE; Soerensen MS; Yilmaz M; Petersen MM
SAGE Open Med; 2022; 10():20503121221094190. PubMed ID: 35492888
[TBL] [Abstract][Full Text] [Related]
62. Unplanned Reoperation and Implant Revision After Total Wrist Arthroplasty.
Pong TM; van Leeuwen WF; Oflazoglu K; Blazar PE; Chen N
Hand (N Y); 2022 Jan; 17(1):114-118. PubMed ID: 32009458
[No Abstract] [Full Text] [Related]
63. Sensitization to Implant Components Is Associated with Joint Replacement Failure: Identification and Revision to Nonallergenic Hardware Improves Outcomes.
Mayer AS; Erb S; Kim RH; Dennis DA; Shirname-More L; Pratte KA; Barker EA; Maier LA; Pacheco KA
J Allergy Clin Immunol Pract; 2021 Aug; 9(8):3109-3117.e1. PubMed ID: 33744472
[TBL] [Abstract][Full Text] [Related]
64. [Very rare cases of periprosthetic malignant neoplasms : Data from 4000 cases of endoprosthetic joint replacements from the histopathologic implant register].
Keidel K; Thomsen M; Dierkes C; Haas H; Arnold I; Heller KD; Krenn V; Liebisch M; Otto M; Gehrke T; Krenn V
Orthopade; 2020 Mar; 49(3):248-254. PubMed ID: 31784796
[TBL] [Abstract][Full Text] [Related]
65. Are competing risks models appropriate to describe implant failure?
Sayers A; Evans JT; Whitehouse MR; Blom AW
Acta Orthop; 2018 Jun; 89(3):256-258. PubMed ID: 29521152
[TBL] [Abstract][Full Text] [Related]
66. Infection rates following urologic prosthetic revision without replacement of any device components compared to partial or complete device exchange: a single-center retrospective cohort study.
Campbell SP; Kim CJ; Allkanjari A; Aksenov LI; Dionise ZR; Inouye BM; Lentz AC
Int J Impot Res; 2023 Dec; 35(8):725-730. PubMed ID: 36151320
[TBL] [Abstract][Full Text] [Related]
67. Surgery of skeletal metastases in 306 patients with prostate cancer.
Weiss RJ; Forsberg JA; Wedin R
Acta Orthop; 2012 Feb; 83(1):74-9. PubMed ID: 22206449
[TBL] [Abstract][Full Text] [Related]
68. Estimating implant survival in the presence of competing risks.
Biau DJ; Hamadouche M
Int Orthop; 2011 Feb; 35(2):151-5. PubMed ID: 20652695
[TBL] [Abstract][Full Text] [Related]
69. Life Expectancy After Treatment of Metastatic Bone Disease: An International Trend Analysis.
Rogers DL; Raad M; Rivera JA; Wedin R; Laitinen M; Sørensen MS; Petersen MM; Hilton T; Morris CD; Levin AS; Forsberg JA
J Am Acad Orthop Surg; 2024 Mar; 32(6):e293-e301. PubMed ID: 38241634
[TBL] [Abstract][Full Text] [Related]
70. Incidence of surgical interventions for metastatic bone disease in the extremities: a population-based cohort study.
Skovlund Sørensen M; Hindsø K; Frederik Horstmann P; Troelsen A; Dalsgaard S; Fog T; Zimnicki T; Mørk Petersen M
Acta Oncol; 2019 Apr; 58(4):456-462. PubMed ID: 30632859
[TBL] [Abstract][Full Text] [Related]
71. Development of a scoring system for survival following surgery for metastatic bone disease.
Baumber R; Gerrand C; Cooper M; Aston W
Bone Joint J; 2021 Nov; 103-B(11):1725-1730. PubMed ID: 34719268
[TBL] [Abstract][Full Text] [Related]
72. A scoping review on the surgical management of metastatic bone disease of the extremities.
Kendal JK; Abbott A; Kooner S; Johal H; Puloski SKT; Monument MJ
BMC Musculoskelet Disord; 2018 Aug; 19(1):279. PubMed ID: 30081884
[TBL] [Abstract][Full Text] [Related]
73. The role of prostheses after resection of primary sarcomas of bone.
Morris H
Acta Orthop Scand Suppl; 1997 Feb; 273():86-8. PubMed ID: 9057593
[TBL] [Abstract][Full Text] [Related]
74. Longitudinal survival trends of patients with cancer with surgically managed appendicular metastatic bone disease: systematic review.
Abbott A; Kendal JK; Hewison C; Puloski S; Monument M
Can J Surg; 2021; 64(6):E550-E560. PubMed ID: 34728520
[TBL] [Abstract][Full Text] [Related]
75. Symptomatic Construct Failure after Metastatic Spine Tumor Surgery.
Kumar N; Patel R; Tan JH; Song J; Pandita N; Hey DHW; Lau LL; Liu G; Thambiah J; Wong HK
Asian Spine J; 2021 Aug; 15(4):481-490. PubMed ID: 33108849
[TBL] [Abstract][Full Text] [Related]
76. Reporting implant survival.
Boeckstyns MEH; Merser S; Cool P
J Hand Surg Eur Vol; 2019 Sep; 44(7):761-763. PubMed ID: 31411117
[No Abstract] [Full Text] [Related]
77. Determining the sample size required to establish whether a medical device is non-inferior to an external benchmark.
Sayers A; Crowther MJ; Judge A; Whitehouse MR; Blom AW
BMJ Open; 2017 Aug; 7(8):e015397. PubMed ID: 28851772
[TBL] [Abstract][Full Text] [Related]
78. Does the Duration of Primary and First Revision Surgery Influence the Probability of First and Subsequent Implant Failures after Extremity Sarcoma Resection and Megaprosthetic Reconstruction?
Theil C; Schneider KN; Gosheger G; Dieckmann R; Deventer N; Hardes J; Schmidt-Braekling T; Andreou D
Cancers (Basel); 2021 May; 13(11):. PubMed ID: 34063771
[TBL] [Abstract][Full Text] [Related]
79. Communication in surgical decision-making while managing metastatic bone disease: matching patient expectations with surgical goals.
Barton KI; Hazenbiller O; Freeman G; Kashluba K; Ball M; Aboutaha A; Puloski SKT; Monument MJ
Support Care Cancer; 2021 Feb; 29(2):1111-1119. PubMed ID: 32607597
[TBL] [Abstract][Full Text] [Related]
80. [Handling of retrieved implants in orthopedic surgery : Results of a survey within the framework of the EndoCert initiative].
Osmanski-Zenk K; Haas H; Mittelmeier W; Kluess D
Orthopade; 2018 Mar; 47(3):205-211. PubMed ID: 29396611
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
